Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

ONCOGENEX PHARMACEUTICALS, INC.

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$ACHV

ONCOGENEX PHARMACEUTICALS, INC.

CIK:0000949858|SEC Filings

PLANS OF ORGANIZATION

EX-2.1
ogxi-ex21_418.htm
2017-05-15T00:00:00Z
EX-2.2
d177072dex22.htm
2017-05-24T00:00:00Z
EX-2.2
d177072dex22.htm
2017-05-03T00:00:00Z
EX-2.1
d310875dex21.htm
2017-01-05T00:00:00Z
EX-2.1
d310875dex21.htm
2017-01-05T00:00:00Z
EX-2.1
a04-15370_1ex2d1.htm
2004-12-28T00:00:00Z
EX-2.2
a04-15370_1ex2d2.htm
2004-12-28T00:00:00Z
EX-2.1
a2186005zex-2_1.htm
2008-05-30T00:00:00Z
EX-2.1
a2186005zex-2_1.htm
2008-05-30T00:00:00Z
EX-2.1
v03075exv2w1.txt
2004-11-08T00:00:00Z
EX-2.2
v03075exv2w2.txt
2004-11-08T00:00:00Z
EX-2.3
ex2_3.htm
2008-11-10T00:00:00Z
EX-2.2
ex2_2.htm
2008-11-10T00:00:00Z
EX-2.1
v83095exv2w1.txt
2002-07-25T00:00:00Z